Genetec Technology Berhad (KLSE:GENETEC)
Malaysia · Delayed Price · Currency is MYR 0.3450
-0.0150 (-4.17%)
At close: Aug 28, 2026
Genetec Technology Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 102.85 | 222.68 | 277.6 | 241 | 223.56 | |
Revenue Growth | -53.82% | -19.78% | 15.19% | 7.80% | 130.29% |
Cost of Revenue | 219.21 | 210 | 190.54 | 166.68 | 143.9 |
Gross Profit | -116.37 | 12.68 | 87.07 | 74.33 | 79.66 |
Selling, General & Admin | 15.47 | 33.41 | 16.71 | 17.16 | 17.38 |
Other Operating Expenses | 8.84 | 1.81 | -2.33 | -3.72 | -1.91 |
Operating Expenses | 24.31 | 34.99 | 14.38 | 13.45 | 15.46 |
Operating Income | -140.68 | -22.31 | 72.69 | 60.88 | 64.2 |
Interest Expense | -3.97 | -1.21 | -2.48 | -3.36 | -1.94 |
Interest & Investment Income | 0.37 | 0.88 | 2.31 | 0.3 | 0.04 |
Earnings From Equity Investments | - | - | -0.2 | - | - |
Other Non Operating Income (Expenses) | - | -2.4 | - | - | - |
EBT Excluding Unusual Items | -144.28 | -25.03 | 72.31 | 57.82 | 62.29 |
Gain (Loss) on Sale of Investments | -0.44 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | 0 |
Pretax Income | -144.71 | -25.03 | 72.31 | 57.82 | 62.29 |
Income Tax Expense | 0.24 | -0.07 | 4.67 | 6.09 | 4.16 |
Earnings From Continuing Operations | -144.95 | -24.96 | 67.64 | 51.73 | 58.14 |
Net Income to Company | -144.95 | -24.96 | 67.64 | 51.73 | 58.14 |
Minority Interest in Earnings | - | -6.4 | 1.26 | -1.94 | -1.74 |
Net Income | -144.95 | -31.36 | 68.9 | 49.79 | 56.4 |
Net Income to Common | -144.95 | -31.36 | 68.9 | 49.79 | 56.4 |
Net Income Growth | - | - | 38.39% | -11.73% | - |
Shares Outstanding (Basic) | 774 | 783 | 766 | 690 | 681 |
Shares Outstanding (Diluted) | 774 | 783 | 774 | 723 | 714 |
Shares Change | -1.07% | 1.17% | 6.94% | 1.36% | 6.03% |
EPS (Basic) | -0.19 | -0.04 | 0.09 | 0.07 | 0.08 |
EPS (Diluted) | -0.19 | -0.04 | 0.09 | 0.07 | 0.08 |
EPS Growth | - | - | 28.70% | -12.66% | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -65.45 | -116.14 | 15.89 | 17.54 | -104.26 |
Free Cash Flow Per Share | -0.09 | -0.15 | 0.02 | 0.02 | -0.15 |
Dividend Per Share | - | - | 0.016 | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | -113.15% | 5.70% | 31.36% | 30.84% | 35.63% |
Operating Margin | -136.78% | -10.02% | 26.18% | 25.26% | 28.72% |
Profit Margin | -140.94% | -14.08% | 24.82% | 20.66% | 25.23% |
Free Cash Flow Margin | -63.64% | -52.15% | 5.72% | 7.28% | -46.64% |
EBITDA | -134.66 | -18.22 | 76.64 | 63.76 | 66.59 |
EBITDA Margin | -130.93% | -8.18% | 27.61% | 26.46% | 29.79% |
D&A For EBITDA | 6.02 | 4.09 | 3.95 | 2.88 | 2.39 |
EBIT | -140.68 | -22.31 | 72.69 | 60.88 | 64.2 |
EBIT Margin | -136.78% | -10.02% | 26.18% | 25.26% | 28.72% |
Effective Tax Rate | - | - | 6.46% | 10.54% | 6.68% |